Spot Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$11.4M	Sell	81,600 -138,800	-63%	-$18.9M	1.46%	85
2017 Q2	$26.8M	Buy	220,400 +216,100	+5,026%	+$25.2M	3.98%	12
2017 Q1	$521K	Buy	4,300 +3,700	+617%	+$477K	0.15%	1214
2016 Q4	$73K	Buy	600 +500	+500%	+$61.2K	0.01%	2314
2016 Q3	$12K	Sell	100 -1,400	-93%	-$180K	﹤0.01%	2877
2016 Q2	$175K	Sell	1,500 -46,600	-97%	-$6.61M	0.02%	2287
2016 Q1	$6.7M	Buy	48,100 +39,800	+480%	+$5.84M	0.88%	209
2015 Q4	$1.58M	Buy	8,300 +4,200	+102%	+$734K	0.12%	1167
2015 Q3	$641K	Sell	4,100 -2,400	-37%	-$438K	0.04%	1885
2015 Q2	$1.18M	Buy	6,500 +3,200	+97%	+$552K	0.07%	1520
2015 Q1	$572K	Sell	3,300 -18,200	-85%	-$3.29M	0.04%	2012
2014 Q4	$3.98M	Sell	21,500 -500	-2%	-$92.6K	0.18%	946
2014 Q3	$3.65M	Sell	22,000 -3,200	-13%	-$526K	0.13%	1142
2014 Q2	$3.94M	Buy	25,200 +5,000	+25%	+$789K	0.14%	1135
2014 Q1	$3.07M	Sell	20,200 -17,100	-46%	-$2.72M	0.12%	1169
2013 Q4	$4.96M	Buy	37,300 +300	+0.8%	+$36K	0.19%	874
2013 Q3	$4.3M	Buy	37,000 +26,900	+266%	+$2.95M	0.22%	830
2013 Q2	$932K	Buy	+10,100	New	+$973K	0.05%	1958